| IVE | SPHD | IVE / SPHD | |
| Gain YTD | 10.709 | 8.183 | 131% |
| Net Assets | 49.5B | 3.34B | 1,482% |
| Total Expense Ratio | 0.18 | 0.30 | 60% |
| Turnover | 28.00 | 49.00 | 57% |
| Yield | 1.50 | 4.66 | 32% |
| Fund Existence | 26 years | 14 years | - |
| IVE | SPHD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 68% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 65% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 75% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 85% | 2 days ago 71% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 73% |
| Advances ODDS (%) | 16 days ago 85% | 5 days ago 84% |
| Declines ODDS (%) | 3 days ago 69% | 3 days ago 73% |
| BollingerBands ODDS (%) | 2 days ago 86% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 70% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SMCZ | 5.16 | 0.27 | +5.52% |
| Defiance Daily Target 2X Short SMCI ETF (SMCZ) | |||
| QVML | 45.35 | 0.09 | +0.20% |
| Invesco S&P 500 QVM Multi-factor ETF (QVML) | |||
| HELX | 43.15 | N/A | N/A |
| Franklin Genomic Advancements ETF (HELX) | |||
| ZTR | 6.30 | -0.04 | -0.63% |
| Virtus Total Return Fund | |||
| IDYN | 30.66 | -0.31 | -1.00% |
| iShares International Equity Factor Rotation Active ETF (IDYN) | |||
A.I.dvisor indicates that over the last year, IVE has been loosely correlated with SWK. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if IVE jumps, then SWK could also see price increases.